A randomized controlled trial on effects of different hemostatic sponges in posterior spinal fusion surgeries
Tóm tắt
Spinal fusion surgery is associated with significant blood loss, which may result in potential clinical complications, it is necessary to take safe and effective measures to reduce blood loss in surgery. We perform this study to assess the impact of three different hemostatic materials on perioperative blood loss. We performed a Randomized Controlled Trial research and recruited patients with lumbar disease into the study between November 2013 and March 2015. All the participants were randomly assigned to 3 groups using a simple equal probability randomization scheme: Group A (Stypro hemostatic sponge), Group B (Collagen hemostatic sponge) and Group C (gelatin sponge). We compared postoperative blood loss between these 3 groups. In our study, drainage volume in the first 24 h of patients in Group A and B is significantly smaller, as well as total postoperative volumes of drainage (p < 0.05) during their hospital stay. The drainage volumes in the second 24 h were similar in the 3 groups. We also found that the average drainage Hematocrit (HCT) reduced over time, the average HCT of drainage is 18.04% and 11.72% on the first day and on the second day respectively. Hemostatic collagen sponge demonstrated better hemostasis effects than gelatin sponge with lower volume of postoperative drainage volume and blood loss in posterior spinal fusion surgery. The trial registration number (TRN) of the study is
ISRCTN29254316
and date of registration is 25/10/2016. Our trial was registered retrospectively.
Tài liệu tham khảo
Miao K, Ni S, Zhou X, et al. Hidden blood loss and its influential factors after total hip arthroplasty. J Orthop Surg Res. 2015;10:36.
Sundaram CP, Keenan AC. Evolution of hemostatic agents in surgical practice. Indian J Urol. 2010;26:374–8.
Smorgick Y, Baker KC, Bachison CC, et al. Hidden blood loss during posterior spine fusion surgery. Spine J. 2013;13:877–81.
Walid MS, Abbara M, Tolaymat A, et al. The role of drains in lumbar spine fusion. World Neurosurg. 2012;77:564–8.
Huang YH, Ou CY. Significant blood loss in lumbar fusion surgery for degenerative spine. World Neurosurg. 2015;84:780–5.
Gazzeri R, De Bonis C, Galarza M. Use of a thrombin-gelatin hemostatic matrix (surgiflo) in spinal surgery. Surg Technol Int. 2014;25:280–5.
Wu J, Jin Y, Zhang J, et al. Hemostatic techniques following multilevel posterior lumbar spine surgery: a randomized control trial. J Spinal Disord Tech. 2014;27:442–6.
Cho SK, Yi JS, Park MS, et al. Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. J Bone Joint Surg Am. 2012;94:1952–8.
Aziz O, Athanasiou T, Darzi A. Haemostasis using a ready-to-use collagen sponge coated with activated thrombin and fibrinogen. Surg Technol Int. 2005;14:35–40.
Fiss I, Danne M, Stendel R. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery. Neurol Med Chir (Tokyo). 2007;47:462–7.
Ren Z, Li S, Hui S, et al. Letter concerning “hidden blood loss during posterior spine fusion surgery” by Yossi et al. Spine J. 2015;15:2113–4.
Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58:277–80.